| |
|
|
|
DiaMedica Therapeutics Inc.  
|
|
3.32 -0.06 (-0.02%) |
03-21 10:29 |
|
Open: |
3.39 |
Pre close: |
3.38 |
Target:
|
4.12
|
|
High: |
3.39 |
Low: |
3.3 |
Resistance:
|
3.52
3.80
|
|
Volume: |
9,534 |
Market Cap: |
40M |
Support:
|
3.08
2.56
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.30
 |
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
3.38  |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
4.57 |
Stochastic Oscillator |
%K(14,3):
|
35.35 |
|
MA(250): |
0.00 |
%D(3): |
31.61 |
|
Average Volume(K) |
3-Month: |
3672
|
52-Week |
High:
|
13.77 |
|
10-Days: |
4529 |
Low: |
2.46 |
|
RSI |
RSI(14):
|
46.08 |
Change(%): |
-58.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-861.9 |
Shares Out. (M) |
11.96 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-175.5 |
Shares Float (M) |
11.96 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.60 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
27.590 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.12 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-4.82 |
P/S |
567245696.00 |
|
Operating Margin |
-976.76 |
Levered Free Cash Flow
(M) |
-2.60 |
P/CF |
-8.24 |
|
|
|
|
|
|
